3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Head and Neck Neoplasms
41
Squamous Cell Carcinoma of Head and Neck
37
Prostatic Neoplasms
16
Nasopharyngeal Carcinoma
12
Carcinoma, Non-Small-Cell Lung
12
Glioblastoma
11
Uterine Cervical Neoplasms
10
Gliosarcoma
10
Brain Neoplasms
10
Neoplasm Metastasis
9
Carcinoma, Squamous Cell
8
Breast Neoplasms
8
Rectal Neoplasms
7
Pancreatic Neoplasms
7
Glioma
7
Carcinoma
7
Tongue Neoplasms
6
Radiation Injuries
6
Oropharyngeal Neoplasms
6
Neoplasms
6
Lung Neoplasms
6
Astrocytoma
6
Sarcoma
5
Nasopharyngeal Neoplasms
5
Papillomavirus Infections
4
Endometrial Neoplasms
4
Salivary Gland Neoplasms
3
Oligodendroglioma
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Interventions
Imatinib Mesylate
3
Radiotherapy
2
Nivolumab
2
relatlimab
1
palbociclib
1
nilotinib
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Proton Therapy
1
Photochemotherapy
1
Pemetrexed
1
Immunoglobulin G
1
Disulfides
1
Dihematoporphyrin Ether
1
Dasatinib
1
Cyclophosphamide
1
Blood Specimen Collection
1
Bacterial Load
1
Afatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Chordoma
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT02520128
2020-12-02
IMRiS
University College, London
Phase NA
Completed
191 enrolled